Sandig V - Search Results

1

Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans.

Dekkers G, Plomp R, Koeleman CA, Visser R, von Horsten HH, Sandig V, Rispens T, Wuhrer M, Vidarsson G. Dekkers G, et al. Among authors: sandig v. Sci Rep. 2016 Nov 22;6:36964. doi: 10.1038/srep36964. Sci Rep. 2016. PMID: 27872474 Free PMC article.

2

Production of non-fucosylated antibodies by co-expression of heterologous GDP-6-deoxy-D-lyxo-4-hexulose reductase.

von Horsten HH, Ogorek C, Blanchard V, Demmler C, Giese C, Winkler K, Kaup M, Berger M, Jordan I, Sandig V. von Horsten HH, et al. Among authors: sandig v. Glycobiology. 2010 Dec;20(12):1607-18. doi: 10.1093/glycob/cwq109. Epub 2010 Jul 15. Glycobiology. 2010. PMID: 20639190

3

Biosynthetic pathway deflection - a new cell line engineering approach.

von Horsten HH, Rose T, Sandig V. von Horsten HH, et al. Among authors: sandig v. BMC Proc. 2011 Nov 22;5 Suppl 8(Suppl 8):O4. doi: 10.1186/1753-6561-5-S8-O4. eCollection 2011. BMC Proc. 2011. PMID: 22373289 Free PMC article. No abstract available.

4

Fucose-targeted glycoengineering of pharmaceutical cell lines.

Ogorek C, Jordan I, Sandig V, von Horsten HH. Ogorek C, et al. Among authors: sandig v. Methods Mol Biol. 2012;907:507-17. doi: 10.1007/978-1-61779-974-7_29. Methods Mol Biol. 2012. PMID: 22907371

5

Engineering of CHO Cells for the Production of Recombinant Glycoprotein Vaccines with Xylosylated N-glycans.

Sandig G, von Horsten HH, Radke L, Blanchard V, Frohme M, Giese C, Sandig V, Hinderlich S. Sandig G, et al. Among authors: sandig v. Bioengineering (Basel). 2017 Apr 28;4(2):38. doi: 10.3390/bioengineering4020038. Bioengineering (Basel). 2017. PMID: 28952517 Free PMC article.

6

In Vitro Evaluation of Glycoengineered RSV-F in the Human Artificial Lymph Node Reactor.

Radke L, Sandig G, Lubitz A, Schließer U, von Horsten HH, Blanchard V, Keil K, Sandig V, Giese C, Hummel M, Hinderlich S, Frohme M. Radke L, et al. Among authors: sandig g, sandig v. Bioengineering (Basel). 2017 Aug 15;4(3):70. doi: 10.3390/bioengineering4030070. Bioengineering (Basel). 2017. PMID: 28952549 Free PMC article.

7

A chemically defined production process for highly attenuated poxviruses.

Jordan I, Northoff S, Thiele M, Hartmann S, Horn D, Höwing K, Bernhardt H, Oehmke S, von Horsten H, Rebeski D, Hinrichsen L, Zelnik V, Mueller W, Sandig V. Jordan I, et al. Among authors: sandig v. Biologicals. 2011 Jan;39(1):50-8. doi: 10.1016/j.biologicals.2010.11.005. Epub 2011 Jan 15. Biologicals. 2011. PMID: 21237672

8

Highly efficient, chemically defined and fully scalable biphasic production of vaccine viruses.

Jordan I, Sandig V. Jordan I, et al. Among authors: sandig v. BMC Proc. 2011 Nov 22;5 Suppl 8(Suppl 8):O1. doi: 10.1186/1753-6561-5-S8-O1. eCollection 2011. BMC Proc. 2011. PMID: 22373097 Free PMC article. No abstract available.

9

An avian cell line designed for production of highly attenuated viruses.

Jordan I, Vos A, Beilfuss S, Neubert A, Breul S, Sandig V. Jordan I, et al. Among authors: sandig v. Vaccine. 2009 Jan 29;27(5):748-56. doi: 10.1016/j.vaccine.2008.11.066. Epub 2008 Dec 9. Vaccine. 2009. PMID: 19071186

10

Cell lines from the Egyptian fruit bat are permissive for modified vaccinia Ankara.

Jordan I, Horn D, Oehmke S, Leendertz FH, Sandig V. Jordan I, et al. Among authors: sandig v. Virus Res. 2009 Oct;145(1):54-62. doi: 10.1016/j.virusres.2009.06.007. Epub 2009 Jun 18. Virus Res. 2009. PMID: 19540275 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters